Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses

Fig. 2

Efficacy, Pairwise Comparisons versus Placebo From Network Meta-Analysis. Pairwise comparisons from the RE informative analysis are shown as rate ratios and 95% CrIs, focusing on comparisons of active comparators versus control (placebo/no treatment) in the network. Values <1 suggest additional benefit with the comparator. A league table of all summary comparisons from the analysis is provided in Fig. 3

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us